Company News

bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.

For 20 years, bioMérieux and the Hospices Civils de Lyon (HCL) have been collaborating in an innovative public/private research partnership. Joined in 2016 by Claude Bernard Lyon 1 University, the three institutions are working to figure out the mechanisms of immunity in order to develop diagnostic tests.

For the third consecutive year, we are awarded a Platinum medal, the highest level distinguishing bioMérieux as part of the Top 1%.

Doing our part to help reduce CO2 emissions through renewable energy.

We were very happy to have rewarded 11 of our most performing Channel Partners with a week in Marcy l'Etoile, France, in our HQ.